WT1 as a Novel Target Antigen for Cancer Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|2|1|45-54

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.2, Iss.1, 2002-03, pp. : 45-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cripto as a target for cancer immunotherapy

By Hu Xiu Feng   Xing Pei Xiang  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 383-394

Informa Healthcare

Access to resources Recommend Favorite

“Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development

By  

Current Medicinal Chemistry, Vol. 15, Iss. 29, 2008-12 ,pp. : 3052-3061

Bentham Science Publishers

Access to resources Recommend Favorite

Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy†

By Madsen Caroline B.   Wandall Hans H.   Pedersen Anders Elm  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 6, 2013-12 ,pp. : 649-652

Informa Healthcare

Access to resources Recommend Favorite

Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3804-3811

Bentham Science Publishers

Access to resources Recommend Favorite

The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target?

By  

Current Cancer Drug Targets, Vol. 8, Iss. 7, 2008-11 ,pp. : 545-553

Bentham Science Publishers

Access to resources Recommend Favorite